ÂÜÀòÂÒÂ×

Douglas An serves as the Sr. Director and Head of Finance and Investor Relations at CG Pharmaceuticals, Inc. since November 2023. Prior to this role, Douglas held the position of Director of Finance at Star Therapeutics from April 2022 to October 2023. Previous experience includes serving as Associate Director of Commercial Finance at AbbVie and Sr. Manager of R&D Financial Planning & Analysis at Novartis Gene Therapies. Douglas has a diverse background in financial planning and analysis, having worked at Menlo Therapeutics Inc. as Head of Financial Planning & Analysis and Investor Relations, and at Relypsa as Finance Manager, FP&A. Earlier roles include financial analyst positions at UBM Tech and Autodesk, and an internship at RGK Consulting as an Investment Banking Analyst. Douglas holds a Bachelor of Arts degree from the University of California, Riverside.